Drug information for ZOFRAN ODT
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, ORALLY DISINTEGRATING; ORAL
4MG
Prescription
AB
ONDANSETRON
Ondansetron
GLAXOSMITHKLINE
20781
2011-12-20 Other Important Information from FDA
2011-09-16 Letter
2011-09-16 Label
2010-09-29 Label
2010-09-27 Letter
2007-09-26 Review
2006-09-18 Letter
2006-08-23 Label
2006-01-06 Letter
2004-12-03 Label
2004-12-02 Letter
2004-07-01 Letter
1999-01-27 Letter
1999-01-27 Review
1999-01-27 Label
TABLET, ORALLY DISINTEGRATING; ORAL
8MG
Prescription
AB (Reference Drug)
ONDANSETRON
Ondansetron
GLAXOSMITHKLINE
"
Drug Adverse Effects information for ZOFRAN ODT
Role code
Indications
Reaction
# Reports
C
MULTIPLE MYELOMA
DYSPHAGIA
2
C
MULTIPLE MYELOMA
FEBRILE NEUTROPENIA
1
C
MULTIPLE MYELOMA
MULTIPLE MYELOMA
2
C
MULTIPLE MYELOMA
PNEUMONIA ASPIRATION
2
C
NAUSEA
MULTIPLE MYELOMA
2
C
PAIN
MULTIPLE MYELOMA
2
C
VOMITING
MULTIPLE MYELOMA
2
Ads by Google